Trial intelligence / Profile preview

Local tranexamic acid in tumescent solution to reduce bleeding during liposuction

IRCT20220221054088N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of tranexamic acid in intraoperative bleeding (2 arms), sponsored by Tehran University of Medical Sciences. Started Mar 2022; status: completed.

02

Drugs

tranexamic acid
03

Conditions

intraoperative bleeding

Beyond the preview

Go deeper on IRCT20220221054088N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220221054088N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call